A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Moderate-to-severe Atopic Dermatitis
Related studies linked through entity extraction aliases.
A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)
- Status
- COMPLETED
- Phase
- PHASE3
The Study of CM326 in Moderate-to-severe Atopic Dermatitis
- Status
- UNKNOWN
- Phase
- PHASE2
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
- Status
- COMPLETED
- Phase
- PHASE4
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Study of CM310 in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3